ID Biomedical reports success in FluINsure trial

01/14/2005 | Forbes

The Canadian drugmaker reports an analysis of data from a trial of its inhaled flu vaccine confirmed it prevents flu symptoms in patients. The firm said it plans to begin pediatric clinical studies of FluINsure in the U.S. later this year. ID Biomedical sells an injected flu vaccine, Fluviral, in Canada.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC